Acute Bipolar Depression: Which Medications to Consider?

This most recent systematic review and network meta-analysis published in Lancet Psychiatry in Sep 2023 is considered the largest network meta-analysis of pharmacotherapy for bipolar depression to date. 

WHAT DID THEY DO?

  • Analysed data from 101 randomized controlled trials
  • Total participants: 20 081
  • 8063 men (41·7%) and 11 263 women (58·3%; sex not available in four studies)
  • Mean age 41·0 years (range of means 28·7-53·6 years)

WHAT DID THEY FOUND?

  • With moderate confidence in the evidence, olanzapine plus fluoxetine, quetiapine, olanzapine, lurasidone, lumateperone, cariprazine, and lamotrigine were more efficacious than placebo in reducing depressive symptoms
  • with SMDs ranging from 0·41 (95% CI 0·19-0·64) for olanzapine plus fluoxetine to 0·16 (0·03-0·29) for lamotrigine.
  • Several other drugs might also be efficacious, but the confidence in the evidence was very low to low.
  • Antidepressants as a class seem to be efficacious, but had a higher risk for manic switch compared to antipsychotics.
  • Medications differed in their side-effect profiles.

FOR ACADEMY MEMBERS:

BIPOLAR DEPRESSION: 6 CLINICAL QUESTIONS

Watch the following 6 clinically relevant discussions by Dr. Lakshmi Yatham

on the topic of Bipolar Depression:

(1) Is Watchful Waiting Appropriate for Bipolar Depression?
(2) Antidepressants in Bipolar Depression: When to Use & When to Avoid?
(3) How Long to Continue Adjunct Antidepressants in Bipolar Depression?
(4) Is Lamotrigine >200 mg Effective for Bipolar Depression?
(5) Is Quetiapine 600 mg More Efficacious than 300 mg for Bipolar Depression?
(6) Which Subgroup of Bipolar Disorder Patients Respond Well to Lithium?

INTERESTED IN ACCESS TO THIS & OTHER CLINICALLY RELEVANT LECTURE SERIES?

JOIN PSYCHIATRY EDUCATION FORUM ACADEMY MEMBERSHIP

This is a closed membership for medical professionals only.

  • 30+ Courses/Sections: Each chapter within these sections is of direct clinical relevance for your daily practice. 
  • Journal Club: we will post the most recently published psychiatry articles relevant to your daily clinical practice.
  • Coffee Club: contain short discussions with clinical experts in the field of psychiatry.
  • Clinical Case Discussions: Discussions of clinical cases from our daily clinical practice. 
  • Discussion Forum & Community: Connect with other medical professionals and discuss your difficult-to-treat clinical cases.
  • Essentials of Inpatient Psychiatry Book: All chapters from this book are included in the academy sections. 
  • Goal: is to have all important clinically relevant topics in one place for ease of access.

JOIN ACADEMY MEMBERSHIP:

GENERAL
$ 99/YR
  •  
STUDENTS
$ 75/YR
  •  

DISCOUNTS AVAILABLE FOR: Residents & Students ONLY.

Email us your student information (program information and way to confirm your student status) to: HSingh@PsychiatryEducationForum.com

Related Articles